• / Free eNewsletters & Magazine
  • / My Account
Home>Shire Drug Cleared to Treat Binge-Eating Disorder -- Update

Shire Drug Cleared to Treat Binge-Eating Disorder -- Update

3party Content

Sat, 31 Jan 2015

By Jonathan D. Rockoff Shire PLC's drug Vyvanse became the first drug approved for sale in the U.S. to treat some of the estimated 2.8 million adults who have a binge-eating disorder. Vyvanse has been in use to treat attention-deficit hyperactivity disorder. The Food and Drug Administration
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.